封面
市场调查报告书
商品编码
1553584

栓塞预防设备市场规模、份额、趋势分析报告:按产品、按应用、按地区、细分市场预测,2024-2030 年

Embolic Protection Devices Market Size, Share & Trends Analysis Report By Product (Distal Occlusion Devices, Proximal Occlusion Devices, Distal Filters), By Application, By Region, And Segment Forecasts, 2024 - 2030

出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10个工作天内

价格
简介目录

栓塞预防设备市场成长与趋势:

Grand View Research 的最新报告显示,到 2030 年,全球栓塞防护设备市场规模预计将达到 10.9 亿美元。

预计 2024 年至 2030 年该市场将以 8.7% 的复合年增长率扩张。心血管和神经血管疾病盛行率的上升以及微创疾病的日益普及正在推动市场成长。对技术先进的栓塞设备的需求不断增长,医疗保健支出不断增加,导致跨国公司投入大量资金和投资,刺激了全球医疗设备产业的研发。这一因素也促进了市场的成长。

另一方面,产品缺陷和召回可能会限制市场成长。支架治疗报销率低以及替代治疗方法(例如使用药物)的存在也可能阻碍市场开拓。然而,经导管主动脉瓣置换术(TAVR)病例数量增加等因素预计将支持市场扩张。

栓塞预防设备市场报告重点

  • 由于对这些设备的高需求,远端过滤设备产业已成为最大的细分市场。
  • 由于神经病变的增加,神经血管疾病在应用中占据最大份额
  • 2023年,北美引领全球栓塞防护设备市场,占最大份额。
  • 微创手术的普及和对新技术不断增长的需求正在推动该地区的主导地位。
  • 由于医疗基础设施的迅速改善和庞大的目标人口基数,预计亚太地区的产业将在预测期内呈现快速成长。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章栓塞预防设备市场变数、趋势与范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 栓塞预防设备市场分析工具
    • 波特的分析
    • PESTEL分析

第四章栓塞预防设备市场:依产品估算与趋势分析

  • 细分仪表板
  • 栓塞预防设备市场:2023 年和 2030 年按产品分類的变化分析
  • 远端封堵器
  • 近端封堵器
  • 远端过滤器

第五章栓塞预防设备市场:依应用估算与趋势分析

  • 细分仪表板
  • 栓塞预防设备市场:2023 年和 2030 年按应用分类的变化分析
  • 心血管疾病
  • 神经血管疾病
  • 周围血管疾病

第六章栓塞预防设备市场:区域估计与趋势分析

  • 2023 年及 2030 年栓塞预防设备市场占有率(按地区)
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Boston Scientific Corporation
    • Edwards Lifesciences Corporation.
    • Abbott.
    • Medtronic
    • Cardinal Health.
    • Innovative Cardiovascular Solutions, LLC
    • Transverse Medical, Inc.
    • WL Gore &Associates, Inc.
简介目录
Product Code: GVR-2-68038-483-3

Embolic Protection Devices Market Growth & Trends:

The global embolic protection devices market size is expected to reach USD 1.09 billion by 2030, according to a new report by Grand View Research, Inc. The market is estimated to expand at a CAGR of 8.7% from 2024 to 2030. Rising incidences of cardiovascular and neurovascular diseases and growing adoption of minimally invasive diseases are propelling the market growth. Rising demand for technologically advanced embolic devices and increasing healthcare expenditure, resulting in huge funding and investments from multinational companies, are fueling the R&D in the global medical devices industry. This factor is also contributing toward the market growth.

On the other hand, the product failures and recalls may limit the market growth. Low reimbursement for stenting and presence of alternative treatment methods, such as the use of drugs, may also imped the market development. However, factors such as a rise in the number of Trans-catheter Aortic Valve Replacement (TAVR) procedures will support the market expansion.

Embolic Protection Devices Market Report Highlights:

  • Distal filter devices segment emerged as the largest segment owing to high demand for these devices
  • Neurovascular diseases accounted for the largest share in the application segment owing to the rising cases of neurological disorders
  • North America led the global embolic protection devices market with the largest share in 2023 and is likely to maintain this trend over the estimated period
  • Growing adoption of minimally invasive surgeries and increasing demand for novel technologies are facilitating the dominance of this region
  • The industry in the Asia Pacific is projected to witness swift growth during the forecast period owing to rapidly improving healthcare infrastructure and large target population base

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Embolic Protection Devices Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Embolic Protection Devices Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Embolic Protection Devices Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Embolic Protection Devices Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Distal Occlusion Devices
    • 4.3.1. Distal Occlusion Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Proximal Occlusion Devices
    • 4.4.1. Proximal Occlusion Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Distal Filters
    • 4.5.1. Ovarian Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Embolic Protection Devices Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Embolic Protection Devices Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Cardiovascular Diseases
    • 5.3.1. Cardiovascular Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Neurovascular Diseases
    • 5.4.1. Neurovascular Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Peripheral Vascular Diseases
    • 5.5.1. Peripheral Vascular Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Embolic Protection Devices Market: Regional Estimates & Trend Analysis

  • 6.1. Embolic Protection Devices Market Share, By Region, 2023 & 2030 (USD Million)
  • 6.2. North America
    • 6.2.1. North America Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. China
      • 6.4.2.1. China Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Japan
      • 6.4.3.1. Japan Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. Australia
      • 6.4.6.1. Australia Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. UAE Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Boston Scientific Corporation
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Edwards Lifesciences Corporation.
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Abbott.
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. Medtronic
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Cardinal Health.
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. Innovative Cardiovascular Solutions, LLC
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Transverse Medical, Inc.
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. W. L. Gore & Associates, Inc.
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives